J&J says it expects to sell $2.5 billion of its Covid-19 vaccine this year — CFO Joseph Wolk joined megtirrell to discuss Q2 results, the spread of the delta variant and more.
The company raised its earnings and revenue guidance for the year. J&J now expects a full-year profit of $9.50 to $9.60 per share, compared with its previous forecast of $9.30 to $9.45 per share. It expects revenue between $92.5 billion and $93.3 billion, compared with its prior forecast of $89.3 billion to $90.3 billion.
They said the company expects data from its study testing two doses of its vaccine in the third quarter or early fourth quarter of this year. The study, which has not yet been peer-reviewed, is at odds with a report from the company, which found the shot is effective against delta, especially against severe disease and hospitalization, even eight months after inoculation.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
J&J forecasts $2.5B in revenue from Covid vaccine sales during 2021Although Johnson & Johnson raised its 2021 revenue estimates, its vaccine sales outlook pales in comparison with its peers, reflecting the widening gap in the global vaccine race.
Read more »
Johnson & Johnson COVID-19 vaccine may not perform as well against Delta variant, says studyThe study, which examined blood samples in a laboratory setting and has not yet been peer-reviewed, suggests that anyone who received the J&J vaccine may...
Read more »
European markets set for strong rebound after global retreat on Covid fearsEuropean stocks are expected to open robustly higher on Tuesday, a day after global markets retreated on fears of a Covid-19 resurgence.
Read more »
J&J raises revenue forecast, estimates $2.5 bln in COVID-19 vaccine salesJohnson & Johnson (JNJ.N) raised its 2021 revenue estimates on Wednesday and forecast it would sell $2.5 billion worth of its COVID-19 vaccine this year, as it strives to quell production and safety problems and catch up with rivals Pfizer and Moderna.
Read more »
Cape Cod COVID-19 cluster grows to more than 130 infected, prompting renewed mitigation effortsOfficials in Provincetown, Massachusetts, issued a number of renewed mitigation measures on Monday after at least 132 individuals tested positive for COVID-19 in the weeks after the holiday weekend.
Read more »
COVID-19 Cases In U.S. Triple Over 2 Weeks Amid MisinformationCOVID-19 cases have tripled in the U.S. over two weeks amid an onslaught of vaccine misinformation.
Read more »